Huberman Lab avatar

Dexa/Huberman Lab

Supported byHuberman Lab
Learn more
Published Aug 23, 2021

Understanding & Conquering Depression | Huberman Lab Podcast #34

Andrew Huberman explores the intricate biology of depression, detailing neurotransmitter and hormonal factors, while presenting a spectrum of evidence-based treatments including lifestyle modifications and revolutionary therapies like ketamine and psilocybin, offering hope through a comprehensive understanding of this complex disorder.
Episode Highlights
Huberman Lab logo

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

  • Neurotransmitters

    explores the intricate roles of norepinephrine, dopamine, and serotonin in depression, highlighting their impact on mood and affective states. He explains that norepinephrine is linked to psychomotor functions, dopamine to pleasure and motivation, and serotonin to emotional aspects like grief and guilt 1. While these neurotransmitters are crucial, Huberman emphasizes the complexity of treating depression, as clinical outcomes often differ from theoretical expectations 2.

    It's very clear that there are at least three major chemical systems in the brain; norepinephrine, dopamine, and serotonin that relate to and can adjust the symptoms of depression.

    ---

    He stresses the importance of understanding these systems to develop effective treatments 3.

       

    Hormonal Impact

    Hormones like thyroid and cortisol significantly influence depression, interacting with genetic predispositions. notes that 20% of those with major depression have low thyroid hormone, affecting energy and metabolism 4. Stress, marked by elevated cortisol, is another critical factor, with repeated stress episodes increasing depression risk 5.

    More stress is correlated with more bouts of major depression across the lifespan.

    ---

    Genetic factors, such as the 5HTTLPR gene, can heighten susceptibility to depression under stress, underscoring the need for stress management strategies 6.

       

    Inflammation

    Inflammation is increasingly recognized as a key player in depression, with inflammatory cytokines affecting neurotransmitter synthesis. explains that excessive inflammation can inhibit serotonin, dopamine, and norepinephrine production, contributing to depressive symptoms 7. Essential fatty acids (EPAs) have shown promise in reducing inflammation and alleviating depression, sometimes matching the efficacy of SSRIs 8.

    There's decent evidence now that inflammation can lead to or exacerbate depression.

    ---

    He emphasizes the importance of managing inflammation to improve mental health outcomes 9.

Related Episodes